The Spermine Oxidase/Spermine Axis Coordinates ATG5-Mediated Autophagy to Orchestrate Renal Senescence and Fibrosis

Dan Luo1,2, Xiaohui Lu1, Hongyu Li1

  • 1Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, NHC Key Laboratory of Clinical Nephrology, Guangdong Provincial Key Laboratory of Nephrology, Guangzhou, Guangdong, 510080, China.

Insights

Spermine oxidase (SMOX) is elevated in fibrotic kidneys, reducing spermine levels. Targeting this axis improves kidney function by enhancing autophagy and reducing senescence, offering a novel therapeutic strategy for renal fibrosis.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Biochemistry

Background:

  • Decreased plasma spermine levels correlate with kidney dysfunction, but its role in kidney disease is unclear.
  • Spermine oxidase (SMOX), involved in polyamine metabolism, is investigated for its role in renal fibrosis.

Purpose of the Study:

  • To investigate the role of spermine oxidase (SMOX) in kidney fibrosis.
  • To explore the therapeutic potential of the SMOX/spermine axis in renal fibrosis.

Main Methods:

  • Assessed SMOX expression in human and mouse fibrotic kidneys.
  • Supplemented with exogenous spermine and utilized genetically deficient SMOX mice.
  • Investigated the interaction between ATG5 and SMOX in fibrotic conditions.

Main Results:

  • SMOX is induced in tubular epithelium of fibrotic kidneys, correlating with fibrosis and kidney function decline.
  • Exogenous spermine or SMOX deficiency improved autophagy, reduced senescence, and attenuated kidney fibrosis.
  • Downregulation of autophagy component ATG5 enhanced SMOX expression and reduced spermine levels.

Conclusions:

  • The SMOX/spermine axis plays a critical role in renal fibrosis.
  • Modulating this axis, potentially by enhancing spermine levels or inhibiting SMOX, could be a novel therapeutic strategy for kidney disease.
  • The findings suggest a link between autophagy, senescence, and the SMOX/spermine pathway in the context of renal fibrosis.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.3K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.5K